194 related articles for article (PubMed ID: 26051171)
1. The efficacy of levetiracetam for patients with supratentorial brain tumors.
Yuan Y; Peizhi Z; Maling G; Wu L; Yunhe M; Xiang W; Qing M; Yanhui L; Ruofei L; Jiewen L
J Clin Neurosci; 2015 Aug; 22(8):1227-31. PubMed ID: 26051171
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
3. Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery.
Zachenhofer I; Donat M; Oberndorfer S; Roessler K
J Neurooncol; 2011 Jan; 101(1):101-6. PubMed ID: 20526797
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam therapy in patients with brain tumour and epilepsy.
Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B
J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
De Smedt T; Raedt R; Vonck K; Boon P
CNS Drug Rev; 2007; 13(1):57-78. PubMed ID: 17461890
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Muti P
J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994
[TBL] [Abstract][Full Text] [Related]
12. The long term retention of levetiracetam in a large cohort of patients with epilepsy.
Depondt C; Yuen AW; Bell GS; Mitchell T; Koepp MJ; Duncan JS; Sander JW
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):101-3. PubMed ID: 16361605
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Chaisewikul R; Privitera MD; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
[TBL] [Abstract][Full Text] [Related]
14. Long-term continuation of levetiracetam in patients with refractory epilepsy.
Krakow K; Walker M; Otoul C; Sander JW
Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
16. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
[TBL] [Abstract][Full Text] [Related]
17. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
[TBL] [Abstract][Full Text] [Related]
18. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
[TBL] [Abstract][Full Text] [Related]
19. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
20. The adverse event profile of levetiracetam: A meta-analysis on children and adults.
Verrotti A; Prezioso G; Di Sabatino F; Franco V; Chiarelli F; Zaccara G
Seizure; 2015 Sep; 31():49-55. PubMed ID: 26362377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
